UTERINE RHABDOMYOSARCOMA

RABDOMIOSSARCOMA UTERINO

dc.creatorRivoire, Waldemar Augusto
dc.creatorMonego, Heleusa Ione
dc.creatorAppel, Márcia
dc.creatordos Reis, Ricardo
dc.creatorL. da Costa, Luiz Augusto
dc.creatorCapp, Edison
dc.date2022-07-27
dc.date.accessioned2022-10-04T21:07:08Z
dc.date.available2022-10-04T21:07:08Z
dc.identifierhttps://seer.ufrgs.br/index.php/hcpa/article/view/126144
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3865971
dc.descriptionUterine rhabdomyosarcomas are very rare. They are characterized by late diagnosis and poor prognosis. In this paper we report clinical manifestations of this tumor in a 37-year-old patient. Rhabdomyosarcomas are treated similarly to endometrial sarcomas. The initial therapy for most uterine sarcomas is exploratory laparotomy, total abdominal hysterectomy, and bilateral salpingo-oophorectomy. There is not much information about the epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas. Because of their rarity, uterine sarcomas are not suitable for screening. They are best managed by specialists with expertise in these malignancies, but primary care physicians can play an important role in the early diagnosis. In suspected cases, endometrial biopsy or dilation and curettage may aid diagnosis.en-US
dc.descriptionRabdomiossarcomas uterinos são raros. São caracterizados por diagnóstico tardio e prognóstico reservado. Neste artigo é relatada a manifestação deste tumor em uma paciente de 37 anos. Rabdomiossarcomas são tratados de forma semelhante à maioria dos sarcomas uterinos. A terapia inicial é laparotomia exploradora, com histerectomia total e salpingoooforectomia bilateral. Devido à baixa freqüência, exames de rastreamento não estão indicados. São melhor tratados por especialistas, mas ginecologistas e clínicos gerais têm papel importante na precocidade do diagnóstico. Em casos suspeitos, biópsia endometrial ou dilatação e curetagem podem auxiliar o diagnóstico.pt-BR
dc.formatapplication/pdf
dc.languagepor
dc.publisherHCPA/FAMED/UFRGSpt-BR
dc.relationhttps://seer.ufrgs.br/index.php/hcpa/article/view/126144/85655
dc.rightshttp://creativecommons.org/licenses/by/4.0pt-BR
dc.sourceClinical & Biomedical Research; Vol. 22 No. 2 (2002): Revista HCPAen-US
dc.sourceClinical and Biomedical Research; v. 22 n. 2 (2002): Revista HCPApt-BR
dc.source2357-9730
dc.subjectRabdomiossarcomapt-BR
dc.subjectsarcoma uterinopt-BR
dc.subjectcâncerpt-BR
dc.subjectsangramento uterinopt-BR
dc.subjectRhabdomyosarcomaen-US
dc.subjectuterine sarcomaen-US
dc.subjectcanceren-US
dc.subjectuterine bleedingen-US
dc.titleUTERINE RHABDOMYOSARCOMAen-US
dc.titleRABDOMIOSSARCOMA UTERINOpt-BR
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Articleen-US
dc.typeAvaliado por parespt-BR


Este ítem pertenece a la siguiente institución